Vaccines

28 Jun 2010 STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year
25 Jun 2010 Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax Administration
24 Jun 2010 Radient Phamacueticals Strategic Partner Jaiva Technologies Plans to Submit Application for Phase II Human Clinical Trials for Non-Small Cell Lung Carcinoma; Advancing Commercialization of RPC's CIT(TM) Cancer Vaccine in India
24 Jun 2010 Crucell Announces Start of Universal RSV Vaccine Program
23 Jun 2010 ImmunoCellular Therapeutics Announces Licensing Agreement with Targepeutics for Worldwide Intellectual Property Rights to Validated Immunotherapy Targ
22 Jun 2010 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Enters Agreement to Develop and Commercialize Antigen-Based Therapy for Type 1 Diabetes
22 Jun 2010 Inovio Pharmaceuticals' Optimized DNA Vaccine Demonstrates Significant Advantages in Non-Human Primates Compared to Leading Viral Vector Based Vaccine
21 Jun 2010 Stallergenes: Staloral(R) Mites 300 Clinical Study in China: Efficacy is Demonstrated
17 Jun 2010 Mymetics' Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania
17 Jun 2010 Merck KGaA Resumes Stimuvax Clinical Program in Lung Cancer
16 Jun 2010 IRX Therapeutics Raises $8 Million to Develop Therapeutic Vaccines for Cancer and Viral Diseases
16 Jun 2010 Vical's Allovectin-7(R) Phase 3 Trial Receives Positive Review From Safety Monitoring Board
15 Jun 2010 Inovio Pharmaceuticals Immunizes First Subject in U.S. Influenza DNA Vaccine Clinical Trial
15 Jun 2010 SCIB1 Immunobody DNA Vaccine Phase I Trial Commences
10 Jun 2010 tellar Biotechnologies Beginning Preclinical Testing
08 Jun 2010 Argos Therapeutics Presents Positive Phase 2 Data for Arcelis Dendritic Cell-based Immunotherapy in Advanced RCC at ASCO
07 Jun 2010 Exceptional Survival Data, Lower Costs Key to the Competitive Advantage of DCVax(R) - Northwest Biotherapeutics' Vaccine for Multiple Cancers
07 Jun 2010 Immunovaccine Signs Agreement with Vaxil BioTherapeutics to Advance Potential Cancer Vaccine
07 Jun 2010 Landmark Study Confirms GRAZAX(R) as the Only Grass Allergy Immunotherapy Tablet to Show Sustained Effect 2 Years After Treatment Completion
04 Jun 2010 Scancell Enters Strategic Collaboration with ImmuneRegen BioSciences
03 Jun 2010 ImmunoCellular Therapeutics' ICT-107 Demonstrates 80 Percent Survival at 2 Years in Phase I Study of Newly Diagnosed Glioblastoma Patients
27 May 2010 ARCA Launches First Therapeutic Trial with GeoVax Vaccine
26 May 2010 Pevion Biotech and CEVEC Pharmaceuticals Sign Exclusive License Option Agreement
26 May 2010 Advaxis Doses First Cervical Dysplasia Clinical Trial Patient
25 May 2010 Vical Collaborators Receive Grant to Pursue Novel CMV Vaccine Strategies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top